Table 1. Univariate analysis and multivariate analysis in NCHCC.
| Variables | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | ||
| Age (≥60) | 1.06 (0.57–1.95) | 0.86 | |||
| Gender (male) | 0.82 (0.45–1.49) | 0.52 | |||
| Family cancer history (yes) | 1.72 (0.95–3.13) | 0.07 | 1.78 (0.93–3.43) | 0.08 | |
| Serum AFP level (≥400) | 0.95 (0.43–2.10) | 0.90 | |||
| Child-Pugh classification (B/A) | 1.13 (0.39–3.22) | 0.83 | |||
| Pathologic stage (III + IV/I + II) | 1.72 (0.93–3.18) | 0.08 | 3.13 (0.34–28.67) | 0.31 | |
| T stage (T3 + T4 + Tx/T1 + T2) | 1.99 (1.09–3.63) | 0.03 | 0.46 (0.05–4.36) | 0.50 | |
| N stage (N1 + N2 + Nx/N0) | 2.15 (1.14–4.04) | 0.02 | 1.35 (0.53–3.48) | 0.53 | |
| M stage (M1 + Mx/M0) | 2.52 (1.33–4.78) | <0.01 | 2.95 (1.16–7.48) | 0.02 | |
| Vessels in tumor (Micro + Macro/none) | 1.12 (0.57–2.20) | 0.75 | |||
| Recurrence (yes) | 1.37 (0.75–2.50) | 0.37 | |||
| SOX9 (high expression) | 2.20 (1.16–4.16) | 0.02 | 2.23 (1.07–4.62) | 0.03 | |
NCHCC, noncirrhotic hepatocellular carcinoma; HR, hazard ratio; CI, confidence interval; AFP, α-fetoprotein; Micro, microvessels; Macro, macrovessels; SOX9, Sex-Determining Region Y-Box 9.